CN Patent

CN106074445B — 包衣药物球状体及其制备消除或减少病症的药物的用途

Assigned to Wyeth LLC · Expires 2018-12-21 · 7y expired

What this patent protects

本发明提供包含激酶抑制剂比如来那替尼的包衣球状体的口服药物制剂，其配制用于减少或消除与现有激酶抑制剂的口服制剂相关的副作用。

USPTO Abstract

本发明提供包含激酶抑制剂比如来那替尼的包衣球状体的口服药物制剂，其配制用于减少或消除与现有激酶抑制剂的口服制剂相关的副作用。

Drugs covered by this patent

pimavanserin-tartrate (PIMAVANSERIN TARTRATE)

Patent Metadata

Patent number: CN106074445B
Jurisdiction: CN
Classification: —
Expires: 2018-12-21
Drug substance claim: No
Drug product claim: No
Assignee: Wyeth LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.